Dr. Ram Nagaraj and a team of researchers have developed a novel molecule, Carboxitin that significantly reduces crosslinking and Advanced Glycation Endproducts (AGEs) formation in eye tissues to reduce lens stiffness. This compound may have the potential to treat diabetic eye complications, cataracts, presbyopia, and age-related macular degeneration.